Caution in interpreting disease‐modification claims with lecanemab: Selective reporting and causal inference

Alzheimer s & Dementia 2026 Open access

Read full text

Authors: Lon S. Schneider, Richard Kennedy, Gary Cutter

DOI: 10.1002/alz.71486

Cited by: 1

References: 1

Fields of Study & Subjects

Advanced Causal Inference Techniques Pharmacovigilance and Adverse Drug Reactions Rheumatoid Arthritis Research and Therapies

References 1